HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ruggero De Maria Selected Research
Ruggero De Maria Research Topics
Disease
115
Neoplasms (Cancer)
03/2022 - 07/2003
17
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2007
16
Breast Neoplasms (Breast Cancer)
01/2021 - 05/2004
12
Glioblastoma (Glioblastoma Multiforme)
01/2020 - 12/2005
8
Neoplasm Metastasis (Metastasis)
03/2022 - 08/2011
8
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 11/2013
7
Colonic Neoplasms (Colon Cancer)
12/2020 - 01/2007
6
Prostatic Neoplasms (Prostate Cancer)
01/2021 - 03/2010
6
Glioma (Gliomas)
01/2017 - 12/2005
6
Male Breast Neoplasms (Male Breast Cancer)
10/2016 - 09/2014
5
Triple Negative Breast Neoplasms
10/2020 - 12/2015
5
Lung Neoplasms (Lung Cancer)
01/2020 - 01/2014
5
Leukemia
06/2014 - 05/2010
5
Thyroid Neoplasms (Thyroid Cancer)
11/2010 - 10/2003
4
Melanoma (Melanoma, Malignant)
12/2020 - 06/2012
3
Disease Progression
01/2022 - 12/2008
3
Obesity
11/2020 - 09/2010
3
Carcinogenesis
07/2019 - 09/2010
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2014 - 01/2008
3
Anemia
11/2013 - 07/2003
3
Multiple Myeloma
11/2012 - 01/2008
3
Anaplastic Thyroid Carcinoma
08/2009 - 05/2007
2
Adenocarcinoma of Lung
12/2021 - 11/2019
2
COVID-19
10/2021 - 06/2020
2
Ductal Carcinoma
12/2020 - 07/2016
2
Adenocarcinoma
08/2020 - 10/2014
2
Infections
06/2020 - 01/2017
2
Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 11/2012
2
Ataxia Telangiectasia (Louis Bar Syndrome)
11/2019 - 01/2018
2
Brain Neoplasms (Brain Tumor)
01/2019 - 01/2013
2
Stomach Neoplasms (Stomach Cancer)
01/2018 - 01/2017
2
Rare Diseases (Rare Disease)
08/2017 - 11/2014
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2016 - 01/2016
2
Residual Neoplasm
12/2015 - 10/2003
2
Chordoma
07/2013 - 09/2006
2
Thrombocytopenia (Thrombopenia)
10/2011 - 05/2007
2
Polycythemia Vera
02/2009 - 05/2006
1
Dyspnea (Shortness of Breath)
04/2022
Drug/Important Bio-Agent (IBA)
18
Proteins (Proteins, Gene)
FDA Link
01/2021 - 10/2003
15
Biomarkers (Surrogate Marker)
IBA
03/2022 - 09/2010
12
MicroRNAs (MicroRNA)
IBA
03/2020 - 01/2008
11
Biological Products
IBA
03/2022 - 09/2006
11
Pharmaceutical Preparations
IBA
03/2022 - 10/2003
10
Phosphotransferases (Kinase)
IBA
01/2022 - 06/2007
8
Cytokines
IBA
01/2022 - 02/2006
7
Hormones (Hormone)
IBA
01/2019 - 09/2010
6
pertuzumab
IBA
01/2021 - 01/2017
5
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 12/2011
5
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
07/2018 - 06/2012
5
Messenger RNA (mRNA)
IBA
01/2017 - 12/2008
5
Ligands
IBA
10/2012 - 11/2004
5
Interleukin-4 (Interleukin 4)
IBA
08/2009 - 10/2003
4
DNA (Deoxyribonucleic Acid)
IBA
11/2021 - 07/2015
4
Trastuzumab (Herceptin)
FDA Link
12/2020 - 10/2014
4
Interleukin-10 (Interleukin 10)
IBA
08/2009 - 10/2003
4
Death Domain Receptors
IBA
05/2007 - 05/2004
3
Ado-Trastuzumab Emtansine
IBA
01/2021 - 01/2017
3
Integrins
IBA
12/2020 - 06/2013
3
Antagomirs
IBA
03/2020 - 01/2008
3
Antineoplastic Agents (Antineoplastics)
IBA
08/2019 - 06/2008
3
Oncogene Proteins (Oncogene Protein)
IBA
06/2016 - 06/2007
3
Estrogen Receptors
IBA
11/2015 - 10/2014
3
Androgen Antagonists (Antiandrogens)
IBA
11/2015 - 11/2014
3
Androgen Receptors (Androgen Receptor)
IBA
11/2015 - 01/2013
3
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
05/2015 - 09/2014
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2015 - 12/2010
3
Caspase 8 (Caspase-8)
IBA
05/2010 - 12/2005
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2007 - 11/2004
2
C-Reactive Protein
IBA
04/2022 - 10/2021
2
human ERBB2 protein
IBA
01/2022 - 01/2021
2
Immune Checkpoint Inhibitors
IBA
12/2021 - 01/2020
2
prexasertib
IBA
04/2021 - 01/2018
2
Antigens
IBA
01/2020 - 03/2002
2
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
11/2019 - 01/2018
2
Catenins
IBA
10/2017 - 03/2014
2
Fluorouracil (Carac)
FDA Link
Generic
10/2017 - 09/2010
2
Phenobarbital (Luminal)
FDA Link
04/2016 - 10/2014
2
Cyproterone Acetate
IBA
05/2015 - 11/2014
2
Aromatase Inhibitors
IBA
05/2015 - 09/2014
2
TOR Serine-Threonine Kinases
IBA
07/2013 - 06/2012
2
Aldehyde Dehydrogenase
IBA
11/2012 - 11/2010
2
Therapeutic Uses
IBA
11/2012 - 12/2005
2
Stem Cell Factor
IBA
10/2011 - 05/2007
2
Temozolomide (Temodar)
FDA Link
Generic
04/2010 - 12/2008
2
Small Interfering RNA (siRNA)
IBA
06/2008 - 02/2006
2
Bortezomib (Velcade)
FDA Link
01/2008 - 05/2007
2
Interleukins
IBA
06/2007 - 02/2006
2
Neutralizing Antibodies
IBA
02/2006 - 10/2003
1
Urea (Carbamide)
FDA Link
Generic
04/2022
1
Nitrogen
IBA
04/2022
1
fibrin fragment D (D-dimer)
IBA
04/2022
Therapy/Procedure
52
Therapeutics
03/2022 - 01/2007
31
Drug Therapy (Chemotherapy)
08/2021 - 07/2003
6
Neoadjuvant Therapy
01/2017 - 10/2014
5
Immunotherapy
12/2021 - 01/2015
5
Radiotherapy
05/2017 - 12/2008
4
Precision Medicine
01/2021 - 01/2015
3
Lasers (Laser)
08/2020 - 03/2013
2
Molecular Targeted Therapy
07/2013 - 01/2011
2
Heterologous Transplantation (Xenotransplantation)
08/2010 - 04/2010